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ABSTRACT 19 
Although microRNAs (miRNAs) play an important role in liver homeostasis, the extent to 20 
which they can be altered by Toxoplasma gondii infection is unknown. Here, we utilized  21 
small RNA sequencing and bioinformatic analyses to characterize miRNA expression profiles 22 
in the liver of domestic cats at 7 days after oral infection with T. gondii (Type II) strain. A 23 
total of 384 miRNAs were identified and 82 were differentially expressed, of which 39 were 24 
up-regulated and 43 down-regulated. Also, 5690 predicted host gene targets for the 25 
differentially expressed miRNAs were identified using the bioinformatic algorithm miRanda. 26 
Gene ontology analysis revealed that the predicted gene targets of the dysregulated miRNAs 27 
were significantly enriched in apoptosis. Kyoto Encyclopedia of Genes and Genomes analysis 28 
showed that the predicted gene targets were involved in several pathways, including acute 29 
myeloid leukemia, central carbon metabolism in cancer, choline metabolism in cancer, 30 
estrogen signaling pathway, fatty acid degradation, lysosome, nucleotide excision repair, 31 
progesterone-mediated oocyte maturation, and VEGF signaling pathway. The expression 32 
level of 6 upregulated miRNAs (mmu-miR-21a-5p, mmu-miR-20a-5p, mmu-miR-17-5p, 33 
mmu-miR-30e-3p, mmu-miR-142a-3p, and mmu-miR-106b-3p) was confirmed by stem-loop 34 
quantitative reverse transcription PCR, which yielded results consistent with the sequencing 35 
data. These findings expand our understanding of the regulatory mechanisms of miRNAs 36 
underlying T. gondii pathogenesis and contribute new database information on cat miRNAs, 37 
opening a new perspective on the prevention and treatment of T. gondii infection. 38 
 39 
Keywords: Toxoplasma gondii, Domestic cat, Liver, Host-pathogen interaction, MircoRNA, 40 
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 42 
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INTRODUCTION 44 
    Toxoplasma gondii is a highly prevalent apicomplexan protozoan parasite, which can 45 
cause serious clinical illnesses in humans and animals [1]. It has been reported to chronically 46 
infect roughly one-third of the world’s human population [2]. T. gondii acquired during 47 
pregnancy may cause damage to the fetus and reactivation of latent infection can cause 48 
life-threatening encephalitis in immune-compromised individuals [3]. This parasite has an 49 
indirect two-host lifecycle, which is composed of asexual reproductive phase in the 50 
intermediate host and sexual reproductive phase in the definitive host (members of the Felidae 51 
family). The enteroepithelial sexual cycle of T. gondii is completed within 3 to 10 days after 52 
ingestion of intermediate host tissue containing T. gondii cysts. T. gondii can also spread 53 
throughout the cat’s body and affect many organs [4-7]. Hence, cats are unique in respect of 54 
their ability to accommodate both sexual and asexual reproductions of T. gondii, making cats 55 
a significant source of infection to humans and animals [2, 8]. 56 
Besides the adverse clinical consequences on humans and other intermediate hosts T. 57 
gondii can cause disseminated and fatal infection in cats [4-7, 9]. Although any organ in the 58 
cat’s body can be affected, clinical cases related to hepatic and pulmonary damage are 59 
particularly important because they are associated with quicker mortality [6,10-12]. Also, 60 
liver  dysfunction, enlargement, icterus, cholangiohepatitis, vomiting, abdominal effusion, 61 
and ascites are complications that frequently occur in T. gondii-infected cats. Therefore, with 62 
the great need for the development of efficacious treatment interventions (due to the lack of a 63 
vaccine and limited efficacies of current therapeutics), it is important to identify the molecular 64 
mechanisms that underpin liver damage caused by T. gondii infection. However, information 65 
4 
 
about the molecular pathways that regulate the interaction between T. gondii and hepatic 66 
tissues has been limited to a few studies [13,14].  67 
The feline genome already encodes roughly 3,182 microRNAs (miRNAs) homologues, 68 
which can regulate the expression of signalling cascades that perform key cellular functions, 69 
such as cell cycle regulation, proliferation, differentiation, apoptosis, and carcinogenesis. 70 
miRNAs constitute a group of endogenous non-coding small RNAs (18 to 25 nucleotides [nt] 71 
long) that regulate gene expression by binding to mRNA and inhibiting translation 72 
[15-18]. miRNAs play an important role in liver homeostasis, and aberrant expression of 73 
miRNAs has been associated with a variety of liver diseases, such as viral hepatitis, 74 
hepatocellular carcinoma and fatty liver disease [19]. Alterations of host miRNA expression 75 
have also been observed in some parasitic infections, such as Cryptosporidium parvum, 76 
Plasmodium falciparum and T. gondii (reviewed in [20]), underscoring the potential role of 77 
miRNAs in mediating the interaction between T. gondii and host cells. Despite the impact of T. 78 
gondii infection on hepatic function the mechanisms underlying the alterations of hepatic 79 
miRNAs expression following acute T. gondii infection remain poorly understood. 80 
  In this study, we hypothesized that T. gondii infection alters the expression of hepatic 81 
miRNAs and that differentially expressed miRNAs mediate the interaction between T. gondii 82 
and cat’s liver. Here we use genome-wide, small RNA sequencing to characterize the global 83 
miRNA transcriptional response of feline liver to infection with T. gondii (Type II) PRU strain. 84 
Our study provides a full picture of the hepatic miRNA repertoire during acute T. gondii 85 
infection in domestic cats, including novel miRNAs, involved in host cell cyclin, apoptosis and 86 
anti-T. gondii defense. 87 
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 88 
RESULTS 89 
 90 
Confirmation of T. gondii infection in the cat livers 91 
Under the conditions we used positive PCR results were obtained, providing laboratory 92 
confirmation of T. gondii infection in the livers of infected cats. RFLP analysis of the positive 93 
PCR amplicons of T. gondii B1 gene revealed a restriction fragment pattern characteristic to 94 
T. gondii genotype II. The livers of control cats and negative PCR control yielded negative 95 
PCR results. 96 
 97 
Analysis of miRNA expression 98 
miRNA libraries of livers from two T. gondii-infected or two control cat groups were 99 
successfully sequenced and sequencing data is summarized in Table 1 and Table 2. Length 100 
distributions of clean reads in the libraries were between 20-24 nt (Fig. 1A-D). A very high 101 
intra-group correlation was detected between the two miRNA libraries of T. gondii-infected 102 
liver samples (R2 =0.989) (Fig. 2A) and the two miRNA libraries of T. gondii-uninfected liver 103 
samples (R2 =0.99) (Fig. 2B). The known and novel mature miRNAs in T. gondii-infected and 104 
control groups were summarized in Table 3 and Table 4. Finally, through comparing T. 105 
gondii-infected and uninfected sRNA libraries, 82 differentially expressed miRNAs were 106 
identified, including 33 up-regulated and 49 down-regulated miRNAs (Table 5).  107 
 108 
Pathway analysis of miRNA targets  109 
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A total of 5690 predicted host targets were identified (Supplementary Table 2). Based on the 110 
predicted targets of the differentially expressed miRNAs GO enrichment analysis was 111 
performed in order to identify the biological processes, molecular functions and cellular 112 
components. The enriched GO terms of the biological processes, molecular functions and 113 
cellular components are shown in Fig. 3A, respectively. KEGG enrichment analysis showed 114 
that target genes were related to multiple pathways, including nucleotide excision repair, 115 
lysosome, vascular endothelial growth factor (VEGF) signaling, estrogen signaling, acute 116 
myeloid leukemia, central carbon metabolism in cancer, choline metabolism in cancer, fatty 117 
acid degradation, progesterone-mediated oocyte maturation, and renal cell carcinoma. The top 118 
20 KEGG enrichment pathways are shown in Fig. 3B. 119 
 120 
miRNA expression validation by qRT-PCR 121 
Six miRNAs, including mmu-miR-21a-5p, mmu-miR-20a-5p, mmu-miR-17-5p, 122 
mmu-miR-30e-3p, mmu-miR-142a-3p, and mmu-miR-106b-3p, were selected for 123 
confirmation by real time PCR to verify the expression levels of the differentially expressed 124 
miRNAs using miRNA specific primers (Supplementary Table 1). The results confirmed that 125 
these selected miRNAs were differentially expressed between infected livers and uninfected 126 
livers and were consistent with the results obtained by RNA-sequencing analysis 127 
(Supplementary Fig 1). Data set from the RNA-sequencing experiment has been deposited in 128 
the GEO database under accession number PRJNA356106. 129 
 130 
DISCUSSION 131 
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    Previous studies showed that T. gondii infection can alter the expression of host 132 
miRNAs, indicating that miRNAs may be involved in the pathogenesis of T. gondii infection 133 
[21-24]. Our results have also shown that acute T. gondii infection alters the level of miRNAs 134 
in the liver of domestic cats. In the present study, we used mall RNA sequencing to identify 135 
cellular miRNAs and signaling pathways involved in the response of cats to T. gondii 136 
infection. Specifically, we determined miRNAs that are differentially expressed by comparing 137 
sham-infected to T. gondii-infected cat livers at 7 dpi. This analysis identified 82 differentially 138 
expressed microRNAs, of which 39 were increased and 43 decreased. By using qRT-PCR, the 139 
expression level of six up-regulated miRNAs (mmu-miR-21a-5p, mmu-miR-20a-5p, 140 
mmu-miR-17-5p, mmu-miR-30e-3p, mmu-miR-142a-3p, and mmu-miR-106b-3p) were 141 
consistent with the results obtained by sequencing analysis. Knowledge of molecular changes 142 
in human liver during the acute phase of toxoplasmosis is lacking due to the mild and subtle 143 
nature of this infection especially in immune-component individuals [1,2]. Hence, these 144 
findings may serve as the basis for understanding the molecular mechanisms associated with 145 
hepatic pathology during acute T. gondii infection.  146 
Differentially expressed miRNAs were associated with signalling pathways involved 147 
mainly in cell cycling, apoptosis, oncogenesis, and host defense. Among the differentially 148 
expressed miRNAs, miR-21a-5p, miR-17-5p, miR-223-3p, miR-27a-5p, miR-126, and 149 
miR-486 were significantly upregulated in T. gondii-infected livers compared to controls. Of 150 
note, the level of miR-21a-5p expression was elevated in various cancer tissues, including 151 
rectal, gastric and lung tissues [25-27] and has been suggested to play a role in tumor biology 152 
[27]. The similarity between the expression of miR-21a-5p during T. gondii infection and 153 
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various forms of cancers is interesting. One striking finding was the correlative link between 154 
upregulation of miR-17-92 in T. gondii-infected human foreskin fibroblasts [28] and in 155 
human astrocyticglioma tissue [29]. The presence of RNA silencing machinery and small 156 
silencing RNAs in T. gondii genome [30] indicates that this parasite has the ability to use its 157 
own miRNAs to interrupt host cell functions in analogy to oncogenic viruses [31].  158 
    miR-17-5p, a key regulator of the G1/S phase cell cycle transition, was up-regulated in 159 
our study in agreement with others who reported overexpression of miR-17-5p in human and 160 
mouse spleen in response to T. gondii infection [21,31]. T. gondii can increase miR-17~92 161 
and miR-106b~25 that play key roles in the regulation of mammalian cell cycle by 162 
influencing the functionally intertwined pathways of apoptosis and G1/S cell cycle 163 
progression [32]. miR-17-5p targets mouse Bcl2l11, Zmat3, Aifm1, and Capn2 to increase 164 
host apoptotic process and targets mouse Ppp3r1 and Akt3 to promote cellular apoptosis 165 
process [21]. Also, miR-17-5p may function as both a tumor suppressor [33] and as an 166 
oncogenic activator [34] by targeting both pro- and anti-proliferative genes and by competing 167 
with each other in different cellular contexts [35]. The effect of T. gondii infection on the 168 
expression of miRNAs (miR-30c-1, miR-125b-2, miR-23b-27b-24-1, and miR-17~92 cluster 169 
genes) that have anti-apoptotic activity has been reported [36]. Modulating these 170 
apoptosis-related miRNAs with mimics or inhibitors can validate their roles in the 171 
dysregulation of host cell apoptotic machinery during T. gondii infection. 172 
  The miR-223-3p has been implicated in the regulation of inflammatory response [37] 173 
and granulocyte production and function [38], and can function as a tumor suppresser in 174 
osteosarcoma by regulating the osteosarcoma cell cycle progression and proliferation [Xu et 175 
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al 2013]. The level of miR-223-3p was significantly increased in infected samples, suggesting 176 
that T. gondii infection of feline liver stimulates the production of miR-223-3p, which plays a 177 
role in the activation of inflammatory response elicited in response to T. gondii infection. This 178 
is concordant with a previous study showing that miRNAs, such as miR-146a and miR-155, 179 
known to activate immune and inflammatory responses can influence host response to T. 180 
gondii infection [39-42]. Also, the upregulation of miR-27a-5p (a regulator of lipid 181 
metabolism-related genes) and miR-21-5p in the infected liver samples suggests that both 182 
miR-27a-5p and miR-21-5p play a role in host response to infection. This assumption is 183 
supported by the association between inhibition of miR-21 and increased Cryptosporidium 184 
parvum burden [29].  185 
miR-126 is associated with tumorigenesis and has recently been found to modulate the 186 
survival and function of Plasmacytoid dendritic cells (pDCs) via positive regulation of the 187 
vascular endothelial growth factor (VEGF) signaling pathway (Ferretti and La Cava, 2014). 188 
miR-126 upregulation may activate Toll-like receptor (TLR)/MyD88 signalling in pDCs 189 
to secrete large amounts of type I interferons (IFNs), which is essential for host resistance to 190 
T. gondii infection. Also, the biological significance of T. gondii-induced upregulation of 191 
miR-486 may lie in its ability to augment the host defense mechanisms. miR-486 has been 192 
shown to activate nuclear factor (NF)-κB signaling pathway [Song et al., 2013], which leads 193 
to the production of proinflammatory cytokines, thereby providing a protection against T. 194 
gondii infection. Of note, both miR-486 and the NF-κB signaling pathway have oncogenic 195 
roles of in human cancers, such as glioma progression [Song et al., 2013]. 196 
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    The let-7 family is a key regulator of the innate immune response. The level of let-7i 197 
during protozoal infection with C. parvum infection was found reduced together with increase 198 
of TLR4 in biliary epithelial cells, contributing to cholangiocyte’s defense responses [43]. In 199 
line with this study our reasults revealed significant downregulation of mmu-let-7f-5p, 200 
mmu-let-7i-5p, mmu-let-7a-5p, mmu-let-7g-5p, mmu-let-7e-5p, and mmu-let-7c-5p in T. 201 
gondii-infected cat’s livers compared with controls. Finally, the fact that miRNAs are host-, 202 
tissue-, and strain-specific [44] explains why the expression of some miRNA (e.g. 203 
miR-712-3p, miR-511-5p and miR-217-5p) that are dysregulated during T. gondii infection 204 
[45] was not altered in our study. 205 
    In conclusion, these findings provided new insight regarding the ability of T. gondii to 206 
alter the expression of 82 microRNAs in cat’s livers. Our study revealed that through 207 
reprogramming of hepatic miRNAs expression T. gondii influences the cellular 208 
microenvironment and host anti-T. gondii response, which are likely to play roles in the parasite 209 
pathogenesis. GO analysis revealed that the predicted targets of the differentially expressed 210 
miRNAs were involved in the regulation of cell cycle and most of the identified KEGG 211 
pathways were related to cancer. Considering the immunoregulatory effects of miRNAs and 212 
their ability to modulate crucial host cellular targets needed for T. gondii replication, miRNAs 213 
may hold promise as biomarkers for prediction of disease progression. Finally, miRNA 214 
pathways that are stimulated during infection may offer potential targets for therapeutic control 215 
of toxoplasmosis.  216 
 217 
MATERIALS AND METHODS 218 
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Ethics Statement 219 
    This study was performed in strict accordance with the recommendations set forth in the 220 
Animal Ethics Procedures and Guidelines of the People’s Republic of China. All animal 221 
experiments were reviewed and approved by the Animal Ethics Committee of Lanzhou 222 
Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Approval No. 223 
LVRIAEC2014-009). Liver tissue collection was performed as a terminal procedure under 224 
isoflurane anesthesia and all efforts were made to minimize suffering. 225 
 226 
Animals, parasite infection and sample collection 227 
    Twelve, 3 month-old, domestic cats (Felis catus) of the Chinese Li Hua breed were 228 
purchased from a local breeder and were housed in a controlled environment. The cats 229 
belonged to two litters, six cats per litter. These 12 cats were randomly allocated to four 230 
groups (two infected and two control) with three cats per group. Before the experiment, all 231 
cats were confirmed to be free from T. gondii using the modified agglutination test and free of 232 
major viral infections (e.g. feline calicivirus and coronavirus, feline immunodeficiency virus, 233 
feline leukemia virus, and feline parvovirus) based on serological examination. Cats were 234 
maintained on commercial cat diets (Royal Canine Inc., St. Charles, MO, USA) and water ad 235 
libitum during the 3 weeks prior to experimentation in order to allow cats to acclimate and to 236 
minimize any potential dietary influence on the study results. During the experiment cats were 237 
individually fed once daily based on daily energy requirements and water was available ad 238 
libitum.  239 
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    Toxoplasma gondii strain used in this study was the PRU strain (Genotype II), which is 240 
maintained in our laboratory by passage through Kunming mice as described previously [46]. 241 
T. gondii type II was used in this study because it seems to be the predominant genotype 242 
circulating in cats [Herrmann et al. 2010; Maksimov P et al. 2013; Brennan et al., 2016]. 243 
Also, the PRU strain is able to produce brain tissue cysts in mouse and oocysts in the gut of 244 
cats and is thus a suitable candidate for a standardized challenge model in cats. The number of 245 
T. gondii cysts was determined using an optical microscope and was adjusted to 100 cysts 246 
mL−1 in phosphate buffered saline (PBS), pH 7.4. Each cat was infected by intragrastric 247 
inoculation with 100 cysts in 1 mL PBS. Control cats were sham-infected with PBS only. 248 
Livers were harvested 7 days after infection in order to allow sufficient time for the infection 249 
to be established in the liver [1]. Collected livers were rinsed extensively in saline, flash 250 
frozen in liquid nitrogen, and stored at −80°C until processing. 251 
 252 
Detection of infection in the liver 253 
    Genomic DNA was extracted from the collected liver samples using TIANamp Genomic 254 
DNA kit according to the manufacturer’s recommendations (TianGen™, Beijing, China). 255 
Then, a semi-nested PCR targeting T. gondii B1 gene was performed to detect T. gondii 256 
infection [47]. DNA samples giving positive B1 amplification were genotyped using 257 
PCR-restriction fragment length polymorphism analysis as described previously [48]. 258 
 259 
RNA extraction and qualification 260 
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    Total RNA was prepared individually from the cryo-preserved liver tissues of the cats 261 
using TRIzol Reagent according to the manufacturer's instructions (Invitrogen Co. Ltd). RNA 262 
degradation and contamination was checked on 1% agarose gels. RNA purity was evaluated 263 
using the NanoPhotometer® spectrophotometer (IMPLEN, CA, USA). RNA concentration 264 
was determined using Qubit® RNA Assay Kit in Qubit® 2.0 Flurometer (Life Technologies, 265 
CA, USA). RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Agilent 266 
Bioanalyzer 2100 system (Agilent Technologies, CA, USA). 267 
 268 
RNA Sequencing library preparation and transcriptomic analysis  269 
 RNA samples from T. gondii-infected and non-infected livers collected at 7 dpi were sent to 270 
Beijing Novogene Bioinformatics Institute for Illumina sequencing. To analyze miRNAs by 271 
sequencing, a total of 3 μg RNAs of three pooled samples from each group were used for the 272 
construction of four small RNA (sRNA) libraries, which were subjected to sequencing on a 273 
Hi-seq 2500 platform. Raw data (raw reads) of fastq format were firstly processed through 274 
custom perl and python scripts. In this step, clean reads were obtained by removing reads 275 
containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, 276 
containing ploy A or T or G or C and low quality reads from raw data. At the same time, Q20, 277 
Q30 and GC-content of the raw data were calculated. Then, we chose a certain range of length 278 
from clean reads to do all downstream analyses. Next, the small RNA tags were mapped to 279 
the feline reference genome sequence using Bowtie software [49]. The following parameters 280 
were used: -k [valid alignments per read], 1; -m [number of possible alignments], 10; -l 281 
[seed length], 25; --best [optimal alignments]). 282 
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    Mapped small RNA tags were used to look for known miRNA. miRBase20.0 was used 283 
as reference, and modified software mirdeep2 [50] and srna-tools-cli were used to obtain the 284 
potential miRNA and draw the secondary structures. Custom scripts were used to obtain the 285 
miRNA counts and base bias on the first position of identified miRNA with certain length and 286 
on each position of all identified miRNA, respectively. To remove tags originating from 287 
protein-coding genes, repeat sequences, rRNA, tRNA, snRNA, and snoRNA, small RNA tags 288 
were mapped to RepeatMasker, Rfam database or those types of data from the specified 289 
species itself. 290 
    The available software miREvo [51] and mirdeep2 [50] were integrated to predict novel 291 
miRNA through exploring the secondary structure, the dicer cleavage site and the minimum 292 
free energy of the small RNA tags unannotated in the former steps. miRNA expression levels 293 
were estimated with TPM (transcript per million) units [52]. Differential expression analysis 294 
of infected versus control groups was performed using the DESeq R package (1.8.3). The 295 
P-values was adjusted using the Benjamini & Hochberg method. Corrected P-value of 0.05 296 
was set as the threshold for significantly differential expression by default.  297 
    Predicting the target gene of miRNA was performed by psRobot_tar in miRanda [53]. 298 
Gene Ontology (GO) enrichment analysis was used to categorize the target genes of the 299 
differentially expressed miRNAs. GOseq based Wallenius non-central hyper-geometric 300 
distribution [54], which could adjust for gene length bias, was implemented for GO 301 
enrichment analysis. The enrichment of target genes in KEGG pathways were tested by the 302 
software KOBAS [55].  303 
 304 
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Validation of miRNA expression 305 
    The stem-loop quantitative reverse transcription PCR was used to validate the results of 306 
miRNA expression analysis as described previously [21,56]. Stem-loop RT-PCR was 307 
performed on ABI PRISM® 7500 Sequence Detection System using SYBR Green 308 
qPCRSuperMix according to the manufacturer's protocol (Invitrogen). All qRT-PCR reactions 309 
were performed in three replicates. Gene expressions were calculated by 2−ΔΔCT relative 310 
expression method as previously described [57]. snRNA U6 was used as normalization 311 
control in qRT-PCR. 312 
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  497 
Table 1: Summary of small RNA sequencing data obtained in the present study. 498 
Library type Reads Bases Error rate Q20 Q30 GC 
content 
Infected liver-1 10665548 0.533G 0.01% 96.21% 92.13% 49.65% 
Infected liver-2 12569494 0.628G 0.01% 96.16% 92.13% 49.98% 
Uninfected liver-1 11727706 0.586G 0.01% 96.24% 92.33% 49.56% 
Uninfected liver-2 10273236 0.514G 0.01% 96.44% 92.60% 49.72% 
499 
25 
 
Table 2: Clean process overview. 500 
Library Infected groups Uninfected groups 
Infected liver 
Group 1 
Infected liver 
Group 2 
Uninfected liver 
Group 1 
Uninfected liver- 
Group 2 
Total reads 10665548 (100.00%) 12569494 (100.00%) 11727706 (100.00%) 10273236 (100.00%) 
N%>10% 531 (0.00%) 636 (0.01%) 606 (0.01%) 540 (0.01%) 
Low quality 40551 (0.38%) 47641 (0.38%) 42076 (0.36%) 32984 (0.32%) 
5_adapter_contamine 1247 (0.01%) 1565 (0.01%) 1026 (0.01%) 915 (0.01%) 
3_adapter_null or insert_null 174157 (1.63%) 176650 (1.41%) 223708 (1.91%) 195007 (1.90%) 
With ployA/T/G/C 10772 (0.10%) 12621 (0.10%) 7991 (0.07%) 6939 (0.07%) 
Clean reads 10438290 (97.87%) 12330381 (98.10%) 11452299 (97.65%) 10036851 (97.70%) 
 501 
502 
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Table 3: Known miRNA mapping. 503 
Criteria Infected groups Uninfected groups 
Infected liver 
Group 1 
Infected liver 
Group 2 
Uninfected liver 
Group 1 
Uninfected liver 
Group 2 
Mapped mature 358 360 348 356 
Mapped hairpin 273 274 266 268 
Mapped uniq 
sRNA 
2531 2604 2411 2409 
Mapped total 
sRNA 
3086174 3665542 3484600 3037510 
 504 
505 
27 
 
Table 4: Novel miRNA mapping. 506 
Types Infected 
liver-1 
Infected liver-2 Uninfected 
liver-1 
Uninfected 
liver-2 
Novel mature 69 76 75 73 
Novel star 10 14 12 10 
Novel hairpin 72 78 80 77 
Mapped uniq 
sRNA 
186 187 161 161 
Mapped total 
sRNA 
12381 12103 13702 7981 
 507 
508 
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Table 5: Differentially expressed miRNAs. 509 
Type miRNA Fold change p-value p-adjustment 
Up-regulated mmu-miR-21a-5p 2.564 1.32E-17 3.15E-15 
 mmu-miR-20a-5p 1.610 3.26E-09 3.88E-07 
 mmu-miR-339-5p 1.839 5.42E-06 0.0002 
 mmu-miR-101a-3p 1.855 8.22E-06 0.0002  
 mmu-miR-320-3p 1.507 9.27E-06 0.0002  
 mmu-miR-195a-5p 1.805 1.33E-05 0.0003 
 mmu-miR-126a-3p 1.486 2.05E-05 0.0003  
 mmu-miR-23a-3p 1.585 2.13E-05 0.0003  
 mmu-miR-140-3p 1.701 2.45E-05 0.0003  
 mmu-miR-28a-5p 1.500 0.0002 0.0018  
 mmu-miR-223-3p 1.917 0.0002  0.0023 
 mmu-miR-30f 1.504 0.0002  0.0023 
 mmu-miR-126a-5p 1.437 0.0003  0.0025  
 mmu-miR-126b-3p 1.435 0.0003  0.0025  
 mmu-miR-17-5p 1.436 0.0005 0.0036  
 mmu-miR-19b-3p 1.485 0.0007 0.0048  
 mmu-miR-27a-5p 1.741 0.0011  0.0076 
 mmu-miR-486b-3p 1.593 0.0011  0.0076 
 mmu-miR-151-3p 1.338 0.0017  0.0093  
 mmu-miR-27a-3p 1.389 0.0017  0.0093  
 mmu-miR-486a-3p 1.571 0.0017 0.0093  
 mmu-miR-99b-5p 1.359 0.0021  0.0106 
 novel_1 1.998 0.0030  0.0134  
 mmu-miR-3074-5p 1.315 0.0049  0.0202 
 mmu-miR-30e-3p 1.325 0.0052  0.0211  
 mmu-miR-24-3p 1.306 0.0055  0.0212 
 mmu-miR-101c 1.0519 0.0069 0.0252 
 mmu-miR-378c 1.528 0.0069 0.0252 
 mmu-miR-486a-5p 1.494 0.0075  0.0271 
 mmu-miR-361-3p 1.379 0.0101 0.0342 
 mmu-miR-106b-3p 1.255 0.0153  0.0451 
 mmu-miR-142a-3p 1.690 0.0152  0.0451 
 mmu-miR-142b 1.690 0.0152  0.0451 
Down-regulate
d 
mmu-let-7f-5p -1.546 1.73E-07 1.38E-05 
 mmu-let-7i-5p -1.705 1.37E-06 6.52E-05 
 mmu-miR-365-3p -1.532 1.24E-06 6.52E-05 
 mmu-miR-148a-3p -1.662 6.17E-06 0.0002 
 mmu-miR-381-3p -2.264 4.87E-06 0.0002 
 mmu-miR-370-3p -2.876 8.54E-06 0.0002  
 mmu-miR-3071-5p -2.007 1.62E-05 0.0003 
29 
 
 mmu-miR-136-3p -1.987 2.23E-05 0.0003  
 mmu-miR-30c-2-3p -1.683 6.94E-05 0.0009  
 mmu-miR-128-3p -1.487 7.45E-05 0.0009  
 mmu-miR-30d-5p -1.358 0.0002 0.0018  
 mmu-let-7a-5p -1.426 0.0002  0.0023 
 mmu-miR-340-5p -1.570 0.0002  0.0023 
 mmu-let-7g-5p -1.349 0.0003 0.0023  
 mmu-miR-493-5p -2.565 0.0003 0.0023  
 mmu-miR-218-5p -1.618 0.0003  0.0025  
 mmu-miR-127-3p -1.517 0.0003  0.0026 
 mmu-let-7e-5p -1.380 0.0006 0.0042  
 mmu-miR-98-5p -1.452 0.0012 0.0077 
 mmu-miR-409-3p -1.919 0.0013  0.0083 
 mmu-let-7c-5p -1.572 0.0015 0.0089 
 mmu-miR-139-5p -1.418 0.0015 0.0089 
 mmu-miR-129b-3p -1.526 0.0017  0.0093  
 mmu-miR-129-5p -1.526 0.0018 0.0095 
 mmu-miR-382-3p -2.192 0.0019 0.0096 
 mmu-miR-193b-3p -1.554 0.0020  0.0102 
 mmu-miR-429-3p -1.738 0.0021 0.0102  
 mmu-miR-181b-5p -1.485 0.0023 0.0109 
 mmu-miR-1b-5p -1.752 0.0024 0.0110  
 mmu-miR-1a-3p -1.751 0.0024  0.0111  
 mmu-miR-450a-5p -1.536 0.0025  0.0112  
 mmu-miR-423-3p -1.296 0.0034  0.0148 
 mmu-miR-328-3p -1.452 0.0035 0.0148  
 mmu-miR-532-5p -1.316 0.0048 0.0200  
 mmu-miR-148a-5p -1.521 0.0055 0.0212 
 mmu-miR-499-5p -1.473 0.0055 0.0212 
 novel_115 -2.137 0.0059  0.0223  
 mmu-miR-425-5p -1.490 0.0080 0.0283  
 mmu-miR-299a-3p -1.481 0.0091  0.0319 
 mmu-miR-200a-3p -1.500 0.0099  0.0342 
 mmu-miR-30b-5p -1.305 0.0104  0.0350  
 mmu-miR-30e-5p -1.486 0.0108 0.0356  
 mmu-miR-200a-5p -1.410 0.0110 0.0358 
 mmu-miR-26a-5p -1.260 0.0113 0.0363  
 mmu-miR-99a-5p -1.379 0.0125 0.0396 
 mmu-miR-409-5p -1.705 0.0127  0.0398 
 mmu-miR-92a-3p -1.350 0.0132 0.0409 
 mmu-miR-129-1-3p -1.769 0.0146  0.0446 
 mmu-miR-148b-3p -1.277 0.0167 0.0484 
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 511 
Figure legends: 512 
 513 
Figure 1: Length distribution of the small RNA expressions in the liver of domestic cats 514 
infected with Toxoplasma gondii compared to control cats. (A and B) Group 1 and group 2 515 
of T. gondii-infected domestic cats; (C and D) Group 1 and group 2 of T. gondii-uninfected, 516 
control, domestic cats.  517 
 518 
Figure 2: Correlation analysis of the small RNA expressions in the livers of T. 519 
gondii-infected and uninfected cats. (A) Correlation analysis of small RNA expression 520 
levels between T. gondii-infected cats of group 1 and group 2; (B) Correlation analysis of 521 
small RNA expression levels between T. gondii-uninfected cats of group 1 and group 2.  522 
 523 
Figure 3: GO enrichment analysis of predicted gene targets of differentially expressed 524 
miRNAs. Abbreviations: IL vs UL: infected liver vs uninfected liver, BP: biological process, 525 
MF: molecular function, CC: cellular component.  526 
 527 
Figure 4: The top 20 enriched pathways of the predicted host targets of the differentially 528 
expressed miRNAs. 529 
  530 
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Supplementary materials 531 
 532 
Supplementary Figure 1: Validation of the differential expression of 6 miRNAs 533 
identified in the sequencing analysis using stem-loop qRT-PCR. U6 was used as a 534 
reference gene. 535 
 536 
Supplementary Table 1: Primers for stem-loop qRT-PCR. 537 
 538 
Supplementary Table 2: Predicted gene targets of differentially expressed miRNAs. 539 
